Literature DB >> 24764791

Reversibility of liver fibrosis.

David A Brenner1.   

Abstract

Entities:  

Year:  2013        PMID： 24764791      PMCID： PMC3995196     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

Review 1.  Anti-fibrogenic strategies and the regression of fibrosis.

Authors:  Tatiana Kisseleva; David A Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

2.  Reversibility of Liver Fibrosis and Inactivation of Fibrogenic Myofibroblasts.

Authors:  Xiao Liu; Jun Xu; David A Brenner; Tatiana Kisseleva
Journal:  Curr Pathobiol Rep       Date:  2013-09

3.  Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis.

Authors:  Tatiana Kisseleva; Min Cong; Yonghan Paik; David Scholten; Chunyan Jiang; Chris Benner; Keiko Iwaisako; Thomas Moore-Morris; Brian Scott; Hidekazu Tsukamoto; Sylvia M Evans; Wolfgang Dillmann; Christopher K Glass; David A Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-07       Impact factor: 11.205

Review 4.  NADPH oxidase mediated oxidative stress in hepatic fibrogenesis.

Authors:  Yong Han Paik; David A Brenner
Journal:  Korean J Hepatol       Date:  2011-12

5.  Inactivation of myofibroblasts during regression of liver fibrosis.

Authors:  Tatiana Kisseleva; David A Brenner
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534
  5 in total
  19 in total

Review 1.  Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement.

Authors:  Ki Tae Suk; Dong Joon Kim
Journal:  World J Hepatol       Date:  2015-03-27

2.  The Therapeutic Potential of Extracellular Vesicles Versus Mesenchymal Stem Cells in Liver Damage.

Authors:  Dina M Rostom; Noha Attia; Hoda M Khalifa; Maha W Abou Nazel; Eshrak A El Sabaawy
Journal:  Tissue Eng Regen Med       Date:  2020-06-06       Impact factor: 4.169

3.  Safety and Utility of Liver Biopsy During Bariatric Surgery in the New Zealand Setting.

Authors:  Hannah Collins; Grant Beban; John Windsor; Rishi Ram; David Orr; Nicholas Evennett; Benjamin Loveday
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

Review 4.  Recent advancement of molecular mechanisms of liver fibrosis.

Authors:  Ekihiro Seki; David A Brenner
Journal:  J Hepatobiliary Pancreat Sci       Date:  2015-04-13       Impact factor: 7.027

5.  Adipose tissue fibrosis.

Authors:  Christa Buechler; Sabrina Krautbauer; Kristina Eisinger
Journal:  World J Diabetes       Date:  2015-05-15

Review 6.  Mechanisms of Lung Fibrosis Resolution.

Authors:  Stephan W Glasser; James S Hagood; Simon Wong; Carmen A Taype; Satish K Madala; William D Hardie
Journal:  Am J Pathol       Date:  2016-03-25       Impact factor: 4.307

7.  Is Elevated Hba1c Level Associated with Achilles Tendon Contracture Development in Diabetic Foot Patients?

Authors:  R A Primadhi; H N Rasyid
Journal:  Malays Orthop J       Date:  2022-03

Review 8.  Two sides of one coin: massive hepatic necrosis and progenitor cell-mediated regeneration in acute liver failure.

Authors:  Hong-Lei Weng; Xiaobo Cai; Xiaodong Yuan; Roman Liebe; Steven Dooley; Hai Li; Tai-Ling Wang
Journal:  Front Physiol       Date:  2015-06-16       Impact factor: 4.566

Review 9.  Pathogenesis of Type 2 Epithelial to Mesenchymal Transition (EMT) in Renal and Hepatic Fibrosis.

Authors:  Anusha H Tennakoon; Takeshi Izawa; Mitsuru Kuwamura; Jyoji Yamate
Journal:  J Clin Med       Date:  2015-12-30       Impact factor: 4.241

10.  Fibronectin expression is critical for liver fibrogenesis in vivo and in vitro.

Authors:  Xiao-Ya Liu; Rui-Xia Liu; Fei Hou; Li-Jian Cui; Chun-Yun Li; Cheng Chi; Entong Yi; Yan Wen; Cheng-Hong Yin
Journal:  Mol Med Rep       Date:  2016-08-25       Impact factor: 2.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.